Dose of hope
Times of India's Edit Page team comprises senior journalists with wide-ranging interests who debate and opine on the news and issues of the day.
To really help, new HIV vax has to be made cheap
A pill to treat multidrug-resistant HIV, lenacapavir, has been approved by US drug regulator FDA as a preventive vaccine. This is a huge deal – incidence of HIV may have declined since 1990s but even today about 13L people globally are infected by the virus every year. But its price is an obstacle. Sold for $28,218 per year in US, it's prohibitive even for high-income nations. Pharma company Gilead that manufactures lenacapavir has reportedly tied up with over 100 middle- and low-income countries for manufacture of generics pending approvals. But access likely will still be tricky for poorer African countries that bear the HIV burden.
Drugs to prevent HIV transmission have been around almost a decade, but a daily dosage regimen makes these unreliable. People forget and there's the stigma/doubt in partners that a daily dose is preventive. Lenacapavir needs to be taken just twice a year. Its long-lasting effect in preventing infection – almost 100% in adults and adolescents – is thus the best bet today. Also because HIV research in US bears the additional burden of Trump administration's slashed funds.
An effective vaccine for HIV has been elusive for decades because of its rapid mutations. Several mRNA vaccines, like those developed for Covid and considered the most promising, are in clinical trials. But since Jan, under Trump's health secretary Bob Kennedy Jr, NIH stopped funding hundreds of such HIV vaccine-related research. This is what makes repurposed lenacapavir a lifeline, provided it's made affordable.
Facebook Twitter Linkedin Email
This piece appeared as an editorial opinion in the print edition of The Times of India.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
31 minutes ago
- Time of India
Hong Kong medical expert recommends annual Covid-19 and flu vaccinations for high-risk groups
Annual Covid-19 vaccination advised for high-risk groups in Hong Kong David Hui Shu-cheong , professor of respiratory medicine at the Chinese University of Hong Kong, has urged that vulnerable groups in Hong Kong receive Covid-19 vaccinations annually. Speaking on Saturday, June 21, Hui noted that outbreaks are expected to recur every six to nine months due to declining antibody levels in the population. 'The current outbreak started in April, peaked at the end of May and is now beginning to subside,' Hui said during a radio interview. He estimated that the present wave may end by July or August. Also read: The pandemic isn't over: New COVID cases are on the rise in Hong Kong, Singapore, Thailand, and other Sout Hui emphasized that high-risk groups, including individuals with chronic illnesses, children, the elderly, and immunocompromised individuals, face greater risks of severe complications, such as pneumonia, respiratory failure, or even death, if infected. Live Events Authorities have confirmed six severe pediatric Covid-19 cases so far in 2025, with no fatalities reported. Two of the children had pre-existing conditions, and four had not received Covid-19 vaccinations. 'As a new outbreak will come back every year, I would advise the high-risk groups to get jabbed at least once every year against the infections,' Hui said. He added that because Covid-19 symptoms often resemble those of seasonal influenza, individuals showing respiratory symptoms should use rapid antigen tests immediately. Early detection allows for timely treatment, which can help prevent complications. Flu season preparations include annual influenza vaccinations In addition to Covid-19 vaccines, Hui recommended annual influenza vaccinations for high-risk individuals. He referenced a recent cluster of influenza A cases at a primary school in Sham Shui Po, involving 46 people, 41 male students aged 7 to 10 and five staff members. Also read: What international travellers should know amidst rising Covid-19 cases Of the infected, 41 sought medical care and three required hospitalization. All cases were mild. Hui attributed the cluster to poor ventilation and inadequate sanitation of shared classroom items. 'Influenza vaccines have been used for many years with extremely low side effects, mainly minor redness and swelling at the injection site,' he said. 'Parents should arrange for their young children to receive the flu vaccines to reduce infection risks.' He warned that Hong Kong's summer flu season typically spans half the summer, usually from July to August. The vaccination rate among children aged six months to two years remains low, with only 27 per cent vaccinated. Professor David Hui of the Chinese University of Hong Kong recommends annual Covid-19 and influenza vaccinations for vulnerable populations, citing recurring outbreaks every six to nine months. He warns that chronically ill individuals, children, and the elderly remain at risk of serious complications without regular immunization and timely testing and treatment Hong Kong medical expert recommends annual Covid-19 and flu vaccinations for high-risk groups Hui concluded by stressing the importance of immunization for reducing public health risks amid ongoing viral transmission cycles.
Time of India
an hour ago
- Time of India
Trump aid cuts deal a blow to HIV prevention in Africa
Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump 's administration cut access for at-risk groups like gay men and injecting drug users to medication that prevents infection. Cherem admits he should have been more careful about practicing safe sex but had become accustomed to using the U.S.-supplied pharmaceutical. The drug - known as Pre-Exposure Prophylaxis, or PrEP - is typically taken daily as a tablet and can reduce the risk of contracting HIV through sex by 99%. "I blame myself... Taking care of myself is my first duty as a person," Cherem said at his gym in Awka, the capital of Nigeria's southeastern state of Anambra. "I equally blame the Trump administration because, you know, these things were available, and then, without prior notice, these things were cut off." Trump ordered a 90-day pause on foreign aid after taking office in January and halted grants by the U.S. Agency for International Development (USAID). The agency was responsible for implementing the bulk of the assistance under the President's Emergency Plan for AIDS Relief ( PEPFAR ), the world's leading HIV/AIDS initiative. Sub-Saharan Africa remains the epicenter of the AIDS pandemic. Trump's cuts have restricted the availability of drugs that millions of Africans have taken to prevent infection - particularly vulnerable communities such as gay men and sex workers - as aid groups and public health systems in Africa strove to roll back the disease. The number of initiations, or people who have taken at least one dose of the drug, rose in Africa from fewer than 700 in 2016 to more than 6 million by late 2024, according to PrEPWatch, a global tracker. More than 90% of new initiations last year were financed by PEPFAR, using cheap generic versions of the drug. Sub-Saharan Africa had 390,000 AIDS-related deaths in 2023, or 62% of the global total, according to UNAIDS, the United Nations AIDS agency. However, progress has been made: that death toll was down by 56% from 2010, according to the World Health Organization. Now, some of those who've lost access to the preventative medication because of U.S. cutbacks are already testing positive, according to 10 patients, health officials and activists. Restrictions on PrEP have coincided with dwindling supplies of more widely used HIV prevention tools like condoms and lubricants "because of the US funding cuts", according to a UNAIDS fact sheet from May. The combination is creating what nine activists and three medical experts described as a major threat to prevention across the continent. "I just see this as incredibly short-sighted because we were on a winning path," said Linda-Gail Bekker, an HIV expert at the University of Cape Town. She said that many African governments did not have the resources to spend on PrEP drugs on top of treatment for HIV infections, risking a worsening of the pandemic. "It's as predictable as if you take your eye off a smouldering bushfire and the wind is blowing: a bushfire will come back." Trump has said that the United States pays disproportionately for foreign aid and he wants other countries to shoulder more of the burden, as he seeks to reduce U.S. government spending across the board. The U.S. disbursed $65 billion in foreign assistance last year, nearly half of it via USAID, according to government data. "It's a question of who has primary responsibility for the health needs of citizens of other countries, and it's their own governments," said Max Primorac , a former senior USAID official who is now senior research fellow at The Heritage Foundation's Margaret Thatcher Center for Freedom. "We all know, and this is a bipartisan issue, that aid dependency doesn't help these people - that the best solution is for these countries to be able to take over the responsibility of these programs." A RISE IN CASES UNAIDS says the permanent discontinuation of PEPFAR-supported prevention and treatment programs could lead to an additional 2,300 new HIV cases globally per day. There were 3,500 new cases per day in 2023. Reuters spoke to 23 health workers, PrEP users and activists, nearly all of whom said that the increase in HIV infections since the funding cuts was impossible to quantify because many organisations working with vulnerable populations have been defunded. A State Department waiver issued on February 1 allowed some PEPFAR activities to restart, but only covered HIV prevention for mother-to-child transmission. That means PEPFAR-financed PrEP is no longer available for gay and bisexual men, sex workers and injecting drug users who are especially exposed to the virus. Many African governments had specifically targeted these groups in their PrEP programs. A spokesperson for the State Department, which oversees USAID and the PEPFAR program, told Reuters it "continues to support lifesaving HIV testing, care and treatment, and prevention of mother to child transmission services approved by the Secretary of State." "All other PEPFAR-funded services are being reviewed for assessment of programmatic efficiencies and consistency with United States foreign policy," the spokesperson said. The spokesperson did not directly respond to a question about why the waiver had excluded vulnerable groups from PrEP distribution. In East and Southern Africa, the sub-region that accounts for more than half of all people living with HIV, the U.S. had been funding nearly 45% of HIV prevention programming, UNAIDS said in March. Some countries like Malawi, Zimbabwe and Mozambique were almost entirely dependent on PEPFAR for their HIV prevention programs, the agency said. In some wealthier nations, like South Africa and Kenya, PEPFAR represented less than 25% of spending on HIV prevention. Russell Vought , the director of the U.S. Office of Management and Budget, told a Congressional committee on June 4 that, due to high U.S. debt levels, Africa needed to shoulder more of the burden in fighting AIDS. Asked specifically about restrictions on HIV prevention programs, Vought said: "We believe that many of these nonprofits are not geared toward the viewpoints of the administration." His office did not respond to a request for further details. 'I PRAY TRUMP CHANGES HIS POLICY' Reuters spoke to four PrEP users in Nigeria, all gay or bisexual men, who have tested positive for HIV since January when they stopped being able to obtain more pills, after practicing unsafe sex. Hearty Empowerment and Rights (HER) Initiative, a community-based organisation in southeastern Nigeria, worked with other groups that provide HIV/AIDS services to confirm the men's diagnosis and help secure treatment for them, said executive director Festus Alex Chinaza. In Asaba, the capital of Nigeria's Delta state, Echezona, a 30-year-old gay man who took PrEP pills daily for more than three years, is struggling to come to terms with his HIV-positive test result, which he received in early May. He regrets that he had unprotected sex. "I just pray and wish that Trump actually changes his policy and everything comes back to normal so that the spread and transmission of the virus would be reduced," said Echezona, who asked to be identified only by his first name for fear of stigma. Like the other three men, he described being told by staff at community-based clinics that PrEP was only available to pregnant and lactating women, in line with the Trump administration guidelines. Nigeria has an adult HIV prevalence rate of 1.3% and an estimated 2 million people living with HIV, the fourth-highest total globally, according to UNAIDS. But for so-called key populations, the rates are much higher: 25% for men who have sex with men, according to a survey completed in 2021. The Nigerian health ministry did not respond to a request for comment on the effects of the Trump administration's cuts to HIV prevention services. South Africa - which has an estimated 7.7 million people living with HIV, according to UNAIDS, the highest number in the world - pays for its own PrEP pills. But some clinics where so-called key populations obtained them relied on PEPFAR grants and have been forced to close in recent months. PrEP is also available for free at public health centers, but gay men and sex workers often avoid such facilities, fearing discrimination and harassment, nine activists said. Francois Venter, executive director of the Ezintsha medical research center at the University of the Witwatersrand in Johannesburg, said PrEP distribution from public sector clinics in the city had shown almost no increase since the Trump cuts. Foster Mohale, spokesperson for South Africa's health ministry, said the ministry was "not aware" of reports that key populations were avoiding health facilities due to stigma. "We have sensitized health officials across the country to create (a) conducive environment for all healthcare seekers/clients to access the service without feeling judged or discriminated against," he said. (Reporting and writing by Robbie Corey-BouletAdditional reporting by Seun Sanni in Awka, Nigeria, Nellie Peyton in Johannesburg, Amindeh Blaise Atabong in Yaounde, Ange Adihe Kasongo in Kinshasa, Maxwell Akalaare Adombila in Accra and Jennifer Rigby in London. Editing by Daniel Flynn)
Hindustan Times
2 hours ago
- Hindustan Times
Ludhiana: Four new cases in district take Covid tally to 64
Jun 21, 2025 09:26 AM IST Four new Covid-19 cases were reported in the district on Friday, taking the tally to 64 cases so far. The new cases include two men aged 51 and 65 and two women aged 42 and 63. All four are said to be either asymptomatic or only mildly symptomatic. As necessary precautionary measures the department advised maintaining hand hygiene and avoiding unnecessary gatherings (HT photo for representation) Of the total 64 cases reported so far, only 27 are positive at present. While 23 of these are in home isolation, four patients are reported to be hospitalised. As many as 34 people have recovered so far. Three people have died of infection. Most of the people reported so far have been vaccinated for Covid. The health department has advised people to wear masks in crowded or poorly ventilated areas. 'If experiencing fever, cough, sore throat, or breathing difficulty, isolate himself, wear a mask, and consult the nearest health center,' the department recently stated in a press release. As necessary precautionary measures the department advised maintaining hand hygiene and avoiding unnecessary gatherings. It also called for ensuring proper ventilation in indoor spaces.
